Pharma Foods International Co., Ltd.
PMDSF
$6.24
$0.643211.50%
OTC PK
| 01/31/2025 | 07/31/2024 | 04/30/2024 | 01/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -6.88% | -16.87% | -21.20% | -20.86% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -6.88% | -16.87% | -21.20% | -20.86% | |
| Cost of Revenue | -12.93% | 2.39% | -15.60% | -18.64% | |
| Gross Profit | -5.36% | -21.42% | -22.60% | -21.40% | |
| SG&A Expenses | 4.13% | -22.79% | -19.35% | -20.50% | |
| Depreciation & Amortization | -21.93% | -10.96% | -11.70% | 94.59% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 0.89% | -16.88% | -18.15% | -19.82% | |
| Operating Income | -128.17% | -16.78% | -39.28% | -34.16% | |
| Income Before Tax | -124.52% | -18.19% | -40.18% | -31.58% | |
| Income Tax Expenses | -123.24% | 843.67% | 3.78% | 16.42% | |
| Earnings from Continuing Operations | -125.72% | -40.33% | -51.56% | -50.78% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -125.72% | -40.33% | -51.53% | -50.83% | |
| EBIT | -128.17% | -16.78% | -39.28% | -34.16% | |
| EBITDA | -107.62% | -12.60% | -37.71% | -29.86% | |
| EPS Basic | -125.50% | -38.68% | -50.22% | -50.73% | |
| Normalized Basic EPS | -126.15% | -7.77% | -38.84% | -31.56% | |
| EPS Diluted | -125.50% | -38.68% | -50.22% | -50.73% | |
| Normalized Diluted EPS | -126.15% | -7.77% | -38.84% | -31.56% | |
| Average Basic Shares Outstanding | 0.66% | -2.69% | -2.64% | -0.17% | |
| Average Diluted Shares Outstanding | 0.66% | -2.69% | -2.64% | -0.17% | |
| Dividend Per Share | 18.30% | 11.31% | -- | -7.58% | |
| Payout Ratio | -- | -- | -- | -- | |